Doggone it-the case is cancelled: Fatal forty DDI: Midazolam, lopinavir/ritonavir, CYP3A4

Erica D. Wittwer, Wayne T. Nicholson, Corinne Wisdo, Catherine Marcucci

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

This case discusses a pharmacokinetic drug interaction between midazolam and ritonavir/lopinavir. Midazolam is a cytochrome P450 3A4 substrate and ritonavir/lopinavir is a 3A4 inhibitor.

Original languageEnglish (US)
Title of host publicationA Case Approach to Perioperative Drug-Drug Interactions
PublisherSpringer New York
Pages393-396
Number of pages4
ISBN (Print)9781461474951, 9781461474944
DOIs
StatePublished - Sep 15 2015

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Doggone it-the case is cancelled: Fatal forty DDI: Midazolam, lopinavir/ritonavir, CYP3A4'. Together they form a unique fingerprint.

  • Cite this

    Wittwer, E. D., Nicholson, W. T., Wisdo, C., & Marcucci, C. (2015). Doggone it-the case is cancelled: Fatal forty DDI: Midazolam, lopinavir/ritonavir, CYP3A4. In A Case Approach to Perioperative Drug-Drug Interactions (pp. 393-396). Springer New York. https://doi.org/10.1007/978-1-4614-7495-1_84